LLY Stock Down on Lower-Than-Expected Sales Guidance for Q4

Eli Lilly and Company’s LLY shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth-quarter …

CouponFollow Extension

6%
OFF

LLY Stock Down On Lower-Than-Expected Sales Guidance For Q4

3 weeks from now

Eli Lilly and Company’s LLY shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth-quarter …

msn.com

7%
OFF

Lilly Stock Drops 7% As 2024 Revenue Projection Falls Short Of …

3 weeks from now

Jan 14, 2025 · After the pharmaceutical behemoth said that its fourth-quarter 2024 sales prediction of $13.5 billion missed earlier guidance by $400 million, Eli Lilly and Company (LLY, …

yahoo.com

32%
OFF

Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion …

3 weeks from now

Jan 14, 2025 · On Tuesday, Eli Lilly and Co (NYSE: LLY) announced that it expects 2024 full-year worldwide revenue to be approximately $45.0 billion, representing a 32% growth compared to …

yahoo.com

6%
OFF

Eli Lilly Stock Tumbles After New Forecasts Show Weight-loss Drug …

3 weeks from now

Jan 14, 2025 · Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations.

yahoo.com

6%
OFF

Eli Lilly Stock Down On Q4 Guidance Miss - MSN

3 weeks from now

Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its …

msn.com

6%
OFF

What's Happening With LLY Stock - Nasdaq

3 weeks from now

Jan 16, 2025 · Eli Lilly stock (NYSE: LLY) fell over 6% on Tuesday, January 14, after it announced that the sales of its obesity drugs are seeing slower than anticipated growth. It has …

nasdaq.com

7%
OFF

Lilly Stock Drops 7% As 2024 Revenue Projection Falls Short Of …

3 weeks from now

Jan 14, 2025 · After the pharmaceutical behemoth said that its fourth-quarter 2024 sales prediction of $13.5 billion missed earlier guidance by $400 million, Eli Lilly and Company (LLY, …

gurufocus.com

6%
OFF

LLY Stock Down On Lower-Than-Expected Sales Guidance For Q4

3 weeks from now

Jan 15, 2025 · Eli Lilly and Company ’s LLY shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth …

tradingview.com

7%
OFF

Eli Lilly Stock Faces Worst Day In Nearly 4 Years On Q4 Weight …

3 weeks from now

Jan 14, 2025 · Shares of Eli Lilly & Co. dropped over 7% on Tuesday morning, reaching levels last seen in late November and marking the stock’s worst day since March 15, 2021. The …

stocktwits.com

6%
OFF

Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip

3 weeks from now

Jan 15, 2025 · Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected …

yahoo.com

10%
OFF

Eli Lilly Falls More Than 10% In A Month: Buy, Sell Or Hold

3 weeks from now

Nov 11, 2024 · Register now to see our 7 Best Stocks for the Next 30 Days report - free today! The stock of Eli Lilly and Company LLY has declined 10.6% in a month.

nasdaq.com

5%
OFF

Eli Lilly Cuts Q4 Sales Forecast, But Analyst Remains Bullish On Stock ...

3 weeks from now

Eli Lilly (LLY) reduced its fourth-quarter sales guidance by 5%, lowering expectations to $13.5 billion. This figure is $400 million below the low end of the company’s prior guidance and ...

msn.com

6%
OFF

Eli Lilly Stock Falls On Lower Q4 Sales Guidance - LLY Stock

3 weeks from now

Jan 16, 2025 · Eli Lilly and Company’s (LLY) shares dropped 6.6% following the release of disappointing fourth-quarter sales and a reduced revenue outlook for 2024. The company’s …

investingsnacks.com

6%
OFF

LLY Stock Down On Lower-Than-Expected Sales Guidance For Q4

3 weeks from now

Jan 15, 2025 · Eli Lilly and Company’s (LLY Quick Quote LLY - Free Report) shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 and …

zacks.com

5%
OFF

Why Eli Lilly (LLY) Stock Is Declining Today - Yahoo Finance

3 weeks from now

Jan 14, 2025 · The shares of pharmaceutical giant Eli Lilly (LLY) are falling 5% today after the company preannounced lower-than-expected fourth-quarter revenue. The firm estimated that it …

yahoo.com

FAQs about LLY Stock Down on Lower-Than-Expected Sales Guidance for Q4 Coupon?

Why did Eli Lilly (LLY) stock trade down 6% Tuesday?

Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. ...

Why did Eli Lilly stock drop 66% on Tuesday?

Eli Lilly and Company’s LLY shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth-quarter sales numbers. The company also issued its total revenue guidance for 2025 at the JP Morgan Healthcare Conference. ...

How much did Eli Lilly & Company make in Q4 2024?

Eli Lilly and Company issued an update on its fourth quarter 2024 earnings guidance on Tuesday, January, 14th. The company issued revenue guidance of $13.5 billion-$13.5 billion, compared to the consensus revenue estimate of $14.0 billion. Did Eli Lilly and Company beat their earnings estimates last quarter? ...

Is Eli Lilly stock a good buy?

Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying Opportunity? Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December scripts boost. The stock is attractively valued at current levels. ...

Why did Eli Lilly cut its full-year revenue guidance?

However, Eli Lilly recently surprised investors when it cut its full-year revenue guidance ahead of an investor conference after sales of its GLP-1 drugs fell short of expectations. Eli Lilly now expects revenue to be approximately $13.5 billion for its fourth quarter and $45 billion for the full year 2024. ...

Is Eli Lilly's stock correction ending?

Summary I think Eli Lilly and Company's stock correction may be ending as demand for key drugs Zepbound and Mounjaro remains strong, despite recent sales guidance cuts. The company's high valuation multiples are justified by robust growth prospects in FY2025 and FY2026 (likely beyond that as well). ...